Patent · US Active

Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors

US7732600B2 · kind B2 · utility

0Cited by

15References

4Claims

0Family size

Assignee

Glaxo Group Limited · GB

Inventors

Markus Bergauer · Verona, IT
Barbara Bertani · Castiglione delle Stiviere, IT
Matteo Biagetti · Verona, IT
Steven Mark Bromidge · Sawbridgeworth, GB
Alessandro Falchi · Sassari, IT
Colin Philip Leslie · Verona, IT
Giancarlo Merlo · Verona, IT
Domenica Antonia Pizzi · Verona, IT
Marilisa Rinaldi · Verona, IT
Luigi Piero Stasi · Verona, IT
Jessica Tibasco · Verona, IT
Antonio Kuok Keong Vong · Warrenpoint, GB
Simon Edward Ward · Peacehaven, GB

Key dates

Filing date	Aug 13, 2009
Grant date	Jun 8, 2010
Priority date	—
Expiry date	Aug 13, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC04B35/632
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are methods for the preparation of compounds of formula (I):wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.